Patients undergone operation
Conditions
Interventions
None listed
Sponsors
Sapporo Medical University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients whom used over 1000 milliliter of volven
Exclusion criteria
Exclusion criteria: preoperative renal failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative renal function after using new type plasma expander | — |
Secondary
| Measure | Time frame |
|---|---|
| the dose of volven during operation and presence of treatment for the recover of renal function | — |
Countries
Japan
Contacts
Public ContactMitsutaka Edanaga
Sapporo Medical University School of Medicine Department of Anesthesiology
Outcome results
None listed